The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS? - Kantarjian H; O'Brien S; Ravandi F; Borthakur G; Faderl S; Bueso-Ramos C; Abruzzo L; Pierce S; Shan J; Issa JP; Garcia-Manero G; Kantarjian, Hagop; et al. (Cancer (0008543X), 2009)